BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 9607410)

  • 21. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O; Blaese RM; Morris JC
    Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma].
    Zhang XF; Ren ZY; Fang FD; Zuo J; Su CB; Wang RZ; Ma WB
    Ai Zheng; 2002 May; 21(5):473-9. PubMed ID: 12452035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
    Hayashi K; Hayashi T; Sun HD; Takeda Y
    Cancer Gene Ther; 2000 Jan; 7(1):45-52. PubMed ID: 10678355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
    Pasanen T; Karppinen A; Alhonen L; Jänne J; Wahlfors J
    Int J Cancer; 2003 Apr; 104(3):380-8. PubMed ID: 12569563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
    Namba H; Tagawa M; Iwadate Y; Kimura M; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1998 Jan; 9(1):5-11. PubMed ID: 9458237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism of HSV-tk transfection and ganciclovir treatment on chemotherapeutic drug sensitivity.
    Van Dillen IJ; Mulder NH; Meijer C; Dam WA; Kamstra E; De Vries L; Meersma GJ; Van der Zee AG; De Vries EF; Vaalburg W; Hospers GA
    J Chemother; 2005 Jun; 17(3):289-96. PubMed ID: 16038523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells.
    Robe PA; Nguyen-Khac M; Jolois O; Rogister B; Merville MP; Bours V
    BMC Cancer; 2005 Apr; 5():32. PubMed ID: 15804364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions.
    Touraine RL; Vahanian N; Ramsey WJ; Blaese RM
    Hum Gene Ther; 1998 Nov; 9(16):2385-91. PubMed ID: 9829537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy.
    Pacholska A; Wirth T; Samaranayake H; Pikkarainen J; Ahmad F; Ylä-Herttuala S
    Cancer Gene Ther; 2012 Dec; 19(12):870-4. PubMed ID: 23079672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
    Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
    Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells.
    Huang Q; Liu XZ; Kang CS; Wang GX; Zhong Y; Pu PY
    Cancer Gene Ther; 2010 Mar; 17(3):192-202. PubMed ID: 19851353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
    Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
    Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells].
    Wang X; Li L; Feng K; Bai L; Pei X
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):628-31. PubMed ID: 11877036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
    Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
    J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats.
    Engelmann C; Panis Y; Bolard J; Diquet B; Fabre M; Nagy H; Soubrane O; Houssin D; Klatzmann D
    Hum Gene Ther; 1999 Jun; 10(9):1545-51. PubMed ID: 10395379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.